Contact Us
Subscribe
e-Edition

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

17°
- Middle Point, OH (45863)
  Today
  
  A mix of clouds and sun with gusty winds. High 23F. Winds W at 20 to 30 mph. Winds could occasionally gust over 40 mph..
  
  Tonight
  
  Cloudy skies this evening will become partly cloudy after midnight. Low 17F. Winds SSW at 10 to 15 mph.
  
  Updated: December 19, 2025 @ 1:31 pm
- Full Forecast

Site search

Home
News
- Local News
Sports
Obituaries
Local Events
Photos
e-Edition
Classifieds

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

51.48 +1.21 (+2.42%)

Streaming Delayed Price Updated: 2:32 PM EST, Dec 19, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Roche Holding AG Basel American Depositary Shares

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

34 35 Next >

Top Biotech Roivant, Formed By Vivek Ramaswamy, Reports Steep Losses, Light Sales ↗

August 14, 2023

The company is working on a treatment for stomach diseases ulcerative colitis and Crohn's disease.

Via Investor's Business Daily

Is TTOO Stock Really Worth $5? Or Just 5 Cents? ↗

August 09, 2023

TTOO stock has been red hot in recent days, but the story of MULN stock should give speculative investors in T2 Biosystems caution.

Via InvestorPlace

Is AbbVie Still a Good Dividend Stock to Buy? ↗

August 08, 2023

Find out if AbbVie can overcome sinking sales of its top-selling product.

Via The Motley Fool

Why Is Aravive Stock Sinking Today? ↗

August 03, 2023

Aravive Inc (NASDAQ: ARAV) shares plunged after the company's Phase 3 AXLerate-OC trial evaluating the safety and efficacy of batiraxcept in platinum-resistant ovarian cancer did not meet its primary...

Via Benzinga

Johnson & Johnson, Other Pharma Makers Anticipate Reformulated Injectable Drugs May Exclude Price Negotiations ↗

July 28, 2023

Cancer drug manufacturers, including Johnson & Johnson (NYSE: JNJ), anticipate that injectable versions of some popular treatments will not be included in U.S.

Via Benzinga

Why Novartis Stock Spiked Today ↗

July 18, 2023

A massive share buyback program and an improved outlook powered a mid-single-digit rise in the drugmaker's shares today.

Via The Motley Fool

Novo Nordisk's Obesity Drug Saxenda Not Included In WHO's Essential Drug List ↗

July 26, 2023

The World Health Organization (WHO) published the new editions of the Model Lists of Essential Medicines (EML) and Essen

Via Benzinga

Tesla's India Move, Adidas Receives Orders For Massive Unsold Yeezy Inventory, Spotify Raises Subscription Prices: Today's Top Stories ↗

July 24, 2023

Wall Street Journal

Via Benzinga

Alnylam Inks Co-Development, Co-Commercialization Pact With Roche For Hypertension Therapy ↗

July 24, 2023

Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) entered a strategic agreement with Roche Holdings AG (OTC: RHHBY) to

Via Benzinga

New Clinical and Real-World Data for Genentech’s Vabysmo at ASRS Reveal Improved Outcomes for People With Two Leading Causes of Vision Loss

July 20, 2023

From Genentech

Via Business Wire

Q2 Earnings Scorecard And Analyst Reports ↗

July 18, 2023

We now have Q2 results from 38 S&P 500 members.

Via Talk Markets

Nvidia Invested $50 million into This AI Drug Discovery Biotech

July 17, 2023

Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from

Via MarketBeat

Topics Artificial Intelligence

2 Nasdaq Stocks That Could Soar This Week ↗

July 16, 2023

BridgeBio Pharma and Roivant Sciences could make big moves this week.

Via The Motley Fool

Hollywood Wants To Use AI Replicas Of Actors, Major US Banks Deliver Q2 Earnings, Artificial Sweetener Aspartame Classified As 'Possible Carcinogen:' Today's Top Stories ↗

July 14, 2023

Benzinga

Via Benzinga

Roivant Surges As Roche Reportedly Considers $7 Billion Drug Takeover ↗

July 14, 2023

The report sent Roivant Sciences higher Friday, but a deal is far from guaranteed.

Via Investor's Business Daily

Republican Presidential Candidate Vivek Ramaswamy Founded Roivant In Discussions With Roche For $7B Stomach Disease(s) Drug Deal ↗

July 14, 2023

Roivant Sciences Ltd (NASDAQ: ROIV), a biotech company founded by Vivek Ramaswamy, a Republican presidential candidate, is reportedly in discussions with Roche Holdings AG (OTC: RHHBY)

Via Benzinga

How Roche Just Cut Top 1% Biotech Stock TG Therapeutics Down A Peg ↗

July 13, 2023

The companies are rivals in the multiple sclerosis treatment realm with Ocrevus and Briumvi.

Via Investor's Business Daily

Roche's Approved Multiple Sclerosis Drug: Subcutaneous Injection At Par With Intravenous Infusion ↗

July 13, 2023

Roche Holdings AG's (OTC: RHHBY) Phase 3 OCARINA II trial evaluating Ocrevus (ocrelizumab) as a twice-a-year 10-minute subcutaneous injection met its primary and secondary endpoints in patients with...

Via Benzinga

Positive Phase III Results for Genentech’s Ocrevus (ocrelizumab) Twice a Year, 10-Minute Subcutaneous Injection in Patients With Multiple Sclerosis

July 13, 2023

From Genentech

Via Business Wire

Four-Year Follow-Up Data for Genentech’s Evrysdi Show Continued Increase in Number of Children With a Severe Form of Spinal Muscular Atrophy (SMA) Able to Sit, Stand and Walk

June 30, 2023

From Genentech

Via Business Wire

Monkeypox Vaccine: Blue Water Biotech Touts Encouraging Preclinical Data From Monkeypox Vaccine Candidate ↗

June 28, 2023

Blue Water Biotech Inc (NASDAQ: BWV) has released preliminary preclinical data that supports the potential use of its norovirus shell and protrusion (S&P) virus-like particle (VLP) platform for the...

Via Benzinga

Agilent Technologies Stock: Ready to Rise off the Floor

June 21, 2023

Agilent Technologies Inc. (NYSE: A) stock is underperforming the market, trading down (19%) year-to-date. Agilent is a leading global provider.

Via MarketBeat

Roche's Bispecific Antibody With Fixed-Duration Treatment Scores FDA Approval For Type Of Lymphoma ↗

June 16, 2023

The FDA approved Roche Holding AG's (OTC: RHHBY) Columvi (glofitamab-gxbm) for relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL) not otherwise specified or large B-cell lymphoma (LBCL)...

Via Benzinga

FDA Approves Genentech’s Columvi, the First and Only Bispecific Antibody With a Fixed-Duration Treatment for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma

June 15, 2023

From Genentech

Via Business Wire

EyePoint's EYP-1901 Tipped to Transform Wet AMD Market, Analyst Predicts Potential $870M Sales by 2035 ↗

June 14, 2023

JonesResearch has initiated coverage of ophthalmic biopharmaceutical company EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) with a Buy rating and

Via Benzinga

New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control ↗

June 09, 2023

Roche Group Holdings AG's (OTC: RHHBY) data from the global phase 3 COMMODORE 1 and 2 studies e

Via Benzinga

New Data Show Genentech’s Subcutaneously Administered Crovalimab Achieved Disease Control and Was Well-Tolerated in People With Paroxysmal Nocturnal Hemoglobinuria (PNH)

June 09, 2023

From Genentech

Via Business Wire

Why Shares of Zentalis Pharmaceuticals Dropped This Week ↗

June 02, 2023

A rash of insider selling meant the stock gave back some of its gains from last week.

Via The Motley Fool

Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class ↗

May 26, 2023

Roche tested its treatment in patients with liver cancer and found "meaningful" results.

Via Investor's Business Daily

Why Shares of Rain Oncology Are Plummeting Today ↗

May 22, 2023

The company released disappointing top-line results for its lead oncology therapy.

Via The Motley Fool

< Previous 1 2

...

11 12 13 14 15 16 17 18 19

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Announcements
Sports
Entertainment
Local Events
Obituaries
Photos
Videos
Online Features

Services

Subscription Services
Submission Forms
Classifieds
Place an Ad
Promote Your Event
Email Alerts
Search
Weather

minstercommunitypost.com
PO Box 155
Minster, OH 45863
Phone: 419-300-1076
Email: editor@minstercommunitypost.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Middle Point, OH (45863)

Today

Tonight

Roche Holding AG Basel American Depositary Shares (OP:RHHBY)

All News about Roche Holding AG Basel American Depositary Shares

Sections

Services